These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12787920)

  • 21. Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion.
    Sato H; Takino T
    Cancer Sci; 2010 Apr; 101(4):843-7. PubMed ID: 20148894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvianolic acid B in vitro inhibited matrix metalloproteinases-1, -2, and -9 activities.
    Liang YH; Li P; Huang QF; Zhao JX; Liu X; Dai MK
    Zhong Xi Yi Jie He Xue Bao; 2009 Feb; 7(2):145-50. PubMed ID: 19216858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases.
    Yao JS; Chen Y; Zhai W; Xu K; Young WL; Yang GY
    Circ Res; 2004 Aug; 95(4):364-71. PubMed ID: 15256478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of tissue factor pathway inhibitor-2 in cancer biology.
    Sierko E; Wojtukiewicz MZ; Kisiel W
    Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig.
    Goetzenich A; Hatam N; Zernecke A; Weber C; Czarnotta T; Autschbach R; Christiansen S
    J Heart Lung Transplant; 2009 Oct; 28(10):1087-93. PubMed ID: 19782292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
    Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
    Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2.
    Xu X; Chen Z; Wang Y; Yamada Y; Steffensen B
    Biochem J; 2005 Nov; 392(Pt 1):127-34. PubMed ID: 16008524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.
    Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K
    Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
    Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay.
    Kälvegren H; Jönsson S; Jonasson L
    Platelets; 2011; 22(8):572-8. PubMed ID: 21756063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin.
    Soslau G; Mason C; Lynch S; Benjamin J; Ashak D; Prakash JM; Moore A; Bagsiyao P; Albert T; Mathew LM; Jost M
    Thromb Haemost; 2014 Jan; 111(1):140-53. PubMed ID: 24136115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells.
    Rodríguez-Calvo R; Ferrán B; Alonso J; Martí-Pàmies I; Aguiló S; Calvayrac O; Rodríguez C; Martínez-González J
    Thromb Haemost; 2015 Jun; 113(6):1323-34. PubMed ID: 25809189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
    Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K
    Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
    Stanton H; Ung L; Fosang AJ
    Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dynamics of matrix metalloproteinases activity of primary murine embryonic fibroblasts during cultivation].
    Voronkina IV; Kirpichnikova KM; Smagina LV; Kozhukharova IV; Gamaleĭ IA
    Tsitologiia; 2011; 53(1):49-54. PubMed ID: 21473119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.